E Agosti
Overview
Explore the profile of E Agosti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agresta G, Campione A, Veiceschi P, Gallo D, Agosti E, Massimi L, et al.
J Endocrinol Invest
. 2022 Dec;
46(6):1219-1232.
PMID: 36550264
Purpose: Craniopharyngiomas (CPGs) are aggressive brain tumors responsible of severe morbidity in children. The best treatment strategies are under debate. Our study evaluates surgical, pituitary, and hypothalamic outcomes of a...
2.
DAmore F, Vinacci G, Agosti E, Cariddi L, Terrana A, Vizzari F, et al.
AJNR Am J Neuroradiol
. 2020 Aug;
41(10):1800-1803.
PMID: 32732268
Since December 2019, a novel Severe Acute Respiratory Syndrome coronavirus 2 from China has rapidly spread worldwide. Although respiratory involvement is the mainstay of coronavirus disease 2019 (COVID-19), systemic involvement...
3.
Casagrande J, Agosti E, Veiceschi P
Acta Neurochir (Wien)
. 2020 Feb;
162(4):937-941.
PMID: 32006187
Background: BacJac™ is a posterior interspinous spacer for selected cases of degenerative lumbar spine diseases. It blocks the metameric vertebral segment in terminal extension, restoring foraminal heights. Methods: The authors...
4.
Bembi B, Zanatta M, Carrozzi M, Baralle F, Gornati R, Berra B, et al.
Lancet
. 1994 Dec;
344(8938):1679-82.
PMID: 7996964
The development of intravenous enzyme-replacement treatment for Gaucher's disease has changed life expectancy in cases without neurological involvement (type 1). The effects in patients with neurological involvement are unknown. We...
5.
Bembi B, Agosti E, Boehm P, Nassimbeni G, Zanatta M, Vidoni L
Acta Paediatr
. 1994 Jan;
83(1):122-4.
PMID: 8193463
Gaucher disease is the most prevalent lysosomal storage disorder. It is characterized by an autosomal recessive inheritance of a deficiency of lysosomal acid glucocerebrosidase. Three clinical phenotypes are recognized: type...
6.
Tuteja R, Bembi B, Agosti E, Baralle F
Hum Mol Genet
. 1993 Jun;
2(6):781-4.
PMID: 8102572
Gaucher disease is the most common of the glycolipid storage diseases and is caused by an inherited deficiency of the enzyme glucocerebrosidase. It is a very heterogeneous disease and presents...
7.
de Manzini A, Andolina M, Agosti E, Giorgi R, Locatelli F, Bonetti L, et al.
Bone Marrow Transplant
. 1993 Jan;
11 Suppl 1:114-6.
PMID: 8448533
2-3 antigens mismatched BMT were performed on 32 children without a matched sibling donor. In the light of previous in vitro studies, which suggested a role of Vincristine and Methilprednisolone...
8.
Bembi B, Comelli M, Scaggiante B, Pineschi A, Rapelli S, Gornati R, et al.
Am J Med Genet
. 1992 Nov;
44(4):527-33.
PMID: 1442900
Five young patients with Niemann-Pick disease type B were treated with repeated implantations of amniotic epithelial cells, as a source of exogenous sphingomyelinase. This treatment abolished the recurrent infections, mainly...
9.
Romanello C, Grossi F, Radillo L, Betterle C, Marinoni S, Agosti E, et al.
Pediatr Med Chir
. 1991 Jul;
13(4):355-8.
PMID: 1754467
A controlled trial was carried out on type I diabetic children to evaluate and to compare the clinical effects of two different kinds of immunotherapy: high doses intravenous gammaglobulin (IVIgG)...
10.
Ventura A, Rinaldi S, Florean P, Agosti E
Pediatr Med Chir
. 1991 Mar;
13(2):169-72.
PMID: 1910165
A dual sugar (lactulose-mannitol) absorption test was performed in 19 patients with atopic eczema before and after a 21 day elimination-diet. Moreover L/M test was carried out in 20 controls....